CrossBridge Bio

CrossBridge Bio is a biotechnology company developing innovative antibody-drug conjugates (ADCs) aimed at revolutionizing cancer treatment. The company leverages proprietary linker technology and enzymatic conjugation methods to create stable, targeted, and potentially synergistic ADC therapies, offering higher efficacy and safety in cancer treatment.